Evidence map›Paper›PMID 36318050›Full record

Trial reportHealth technology assessment (Winchester, England)2022

One-session treatment compared with multisession CBT in children aged 7-16 years with specific phobias: the ASPECT non-inferiority RCT.

Barry Wright, Lucy Tindall, Alexander J Scott, Ellen Lee, Katie Biggs, Cindy Cooper, Penny Bee, Han-I Wang, Lina Gega, Emily Hayward and 18 more

Open access · diamondAbstract readEquivalence TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 2 countries.

Barry WrightCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0002-8692-6001
Lucy TindallCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0002-7486-5037
Alexander J ScottSchool of Psychology, Keele University, Keele, UK.ORCID 0000-0001-7426-7099
Ellen LeeSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0003-4529-7410
Katie BiggsSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0003-4468-7417
Cindy CooperSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0002-2995-5447
Penny BeeSchool of Nursing, Midwifery and Social Care, University of Manchester, Manchester, UK.ORCID 0000-0002-5600-0400
Han-I WangCentre for Health Economics, University of York, York, UK.ORCID 0000-0002-3521-993X
Lina GegaMental Health and Addictions Research Group, Hull York Medical School, University of York, York, UK.ORCID 0000-0003-2902-9256
Emily HaywardCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0002-2413-0104
Kiera SolaimanSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0003-2244-5345
M Dawn TearePopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-3994-0051
Thompson DavisDepartment of Psychology, Louisiana State University, Baton Rouge, LA, USA.ORCID 0000-0002-5180-8822
Karina LovellSchool of Nursing, Midwifery and Social Care, University of Manchester, Manchester, UK.ORCID 0000-0001-8821-895X
Jon WilsonCentral Norfolk Youth Service, Norfolk and Suffolk NHS Foundation Trust, Norwich, UK.ORCID 0000-0002-5279-6237
Dean McMillanCentre for Health Economics, University of York, York, UK.ORCID 0000-0002-2901-8410
Amy BarrSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0002-7990-7451
Hannah EdwardsCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0002-0500-2123
Jennifer LomasSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0002-2446-7153
Chris TurtleSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0003-3109-425X
Steve ParrottCentre for Health Economics, University of York, York, UK.ORCID 0000-0002-0165-1150
Catarina TeigeCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0002-8958-6487
Tim ChaterSheffield Clinical Trials Research Unit, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID 0000-0002-1138-0147
Rebecca HargateCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0001-6532-2375
Shehzad AliMental Health and Addictions Research Group, Hull York Medical School, University of York, York, UK.ORCID 0000-0002-8042-3630
Sarah ParkinsonCOMIC Research Team, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.ORCID 0000-0003-3512-8509
Simon GilbodyMental Health and Addictions Research Group, Hull York Medical School, University of York, York, UK.ORCID 0000-0002-8236-6983
David MarshallCentre for Reviews and Dissemination, University of York, York, UK.ORCID 0000-0001-5969-9539
University of Sheffield · GBLeeds and York Partnership NHS Foundation Trust · GBUniversity of York · GBUniversity of Manchester · GBKeele University · GBLouisiana State University · USNewcastle University · GBNorfolk and Suffolk NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to 10% of children and young people have a specific phobia that can significantly affect their mental health, development and daily functioning. Cognitive-behavioural therapy-based interventions remain the dominant treatment, but limitations to their provision warrant investigation into low-intensity alternatives. One-session treatment is one such alternative that shares cognitive-behavioural therapy principles but has a shorter treatment period.

objectiveThis research investigated the non-inferiority of one-session treatment to cognitive-behavioural therapy for treating specific phobias in children and young people. The acceptability and cost-effectiveness of one-session treatment were examined.

designA pragmatic, multicentre, non-inferiority randomised controlled trial, with embedded economic and qualitative evaluations. SETTINGS: There were 26 sites, including 12 NHS trusts.

participantsParticipants were aged 7-16 years and had a specific phobia defined in accordance with established international clinical criteria.

interventionsParticipants were randomised 1 : 1 to receive one-session treatment or usual-care cognitive-behavioural therapy, and were stratified according to age and phobia severity. Outcome assessors remained blind to treatment allocation.

main outcome measuresThe primary outcome measure was the Behavioural Avoidance Task at 6 months' follow-up. Secondary outcomes included the Anxiety Disorder Interview Schedule, Child Anxiety Impact Scale, Revised Children's Anxiety and Depression Scale, a goal-based outcome measure, Child Health Utility 9D, EuroQol-5 Dimensions Youth version and resource usage. Treatment fidelity was assessed using the Cognitive Behaviour Therapy Scale for Children and Young People and the One-Session Treatment Rating Scale.

resultsA total of 274 participants were recruited, with 268 participants randomised to one-session treatment ( LIMITATIONS: The COVID-19 pandemic meant that 48 children and young people could not complete the primary outcome measure. Service waiting times resulted in some participants not starting therapy before follow-up.

conclusionsOne-session treatment for specific phobia in UK-based child mental health treatment centres is as clinically effective as multisession cognitive-behavioural therapy and highly likely to be cost-saving. Future work could involve improving the implementation of one-session treatment through training and commissioning of improved care pathways.

trial registrationThis trial is registered as ISRCTN19883421.

fundingThis project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in

Indexed as

Cognitive Behavioral TherapyCOVID-19Phobic DisordersAdolescentChildCost-Benefit AnalysisHumansPandemicsQuality of LifeADOLESCENTANXIETYCHILDCOGNITIVE–BEHAVIOURAL THERAPYCOST–BENEFIT ANALYSISMENTAL HEALTHMENTAL HEALTH SERVICESPHOBIC DISORDERSTREATMENT OUTCOMES

Identifiers

PMID36318050
PMCPMC9638885
OpenAlexW4308006246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.